SAN FRANCISCO -- Herculean efforts by scientists and physicians around the world have resulted more than 50 experimental COVID-19 vaccines currently in global clinical trials. The focus in the U.S.
Moderna (MRNA) stock jumped more than 6% on Wednesday after the US Food and Drug Administration agreed to review the drugmaker's first flu shot of the season, reversing course on a decision to reject ...
The new travel advisory that will be implemented from October 4 at 4 a.m. says, "Formulations of the four listed vaccines -- AstraZeneca Covishield, AstraZeneca vaxzevria and Moderna Takeda qualify as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results